American Journal of Physiology-Heart and Circulatory Physiology · 2016 · 28 citations · 57 references
MedicineCardiologyPhysiologyElectrophysiologyPathophysiologyStructural Heart DiseaseAtrial FibrillationCardiac PhysiologyCardiovascular PathophysiologyCongenital Heart DiseaseHeart FailureArrhythmogenic MechanismsAtrial Fibrillation PathophysiologyHeart Failure BiomarkersHeart Failure Molecular MechanismsHeart Failure PhysiologySpectrin Family Proteins
β2-Spectrin is critical for integrating membrane and cytoskeletal domains in excitable and nonexcitable cells. The role of β2-spectrin for vertebrate function is illustrated by dysfunction of β2-spectrin-based pathways in disease. Recently, defects in β2-spectrin association with protein partner ankyrin-B were identified in congenital forms of human arrhythmia. However, the role of β2-spectrin in common forms of acquired heart failure and arrhythmia is unknown. We report that β2-spectrin protein levels are significantly altered in human cardiovascular disease as well as in large and small animal cardiovascular disease models. Specifically, β2-spectrin levels were decreased in atrial samples of patients with atrial fibrillation compared with tissue from patients in sinus rhythm. Furthermore, compared with left ventricular samples from nonfailing hearts, β2-spectrin levels were significantly decreased in left ventricle of ischemic- and nonischemic heart failure patients. Left ventricle samples of canine and murine heart failure models confirm reduced β2-spectrin protein levels. Mechanistically, we identify that β2-spectrin levels are tightly regulated by posttranslational mechanisms, namely Ca(2+)- and calpain-dependent proteases. Furthermore, consistent with this data, we observed Ca(2+)- and calpain-dependent loss of β2-spectrin downstream effector proteins, including ankyrin-B in heart. In summary, our findings illustrate that β2-spectrin and downstream molecules are regulated in multiple forms of cardiovascular disease via Ca(2+)- and calpain-dependent proteolysis.
57
Long-Term Trends in the Incidence of and Survival with Heart Failure
Daniel Levy, Satish Kenchaiah, Martin G. Larson et al. · New England Journal of Medicine · 2002 · 2.2K citations · Full text
Lifetime Risk for Developing Congestive Heart Failure
Donald M. Lloyd‐Jones, Martin G. Larson, Eric Leip et al. · Circulation · 2002 · 1.6K citations
Medicine, Cardiology, Aging +16
Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death
Peter J. Mohler, Jean‐Jacques Schott, Anthony O. Gramolini et al. · Nature · 2003 · 960 citations
Medicine, Cardiology, Genetics +15